Exclusive

Publication

Byline

Location

Clinical Trial: North Jersey Community Research Initiative (NJCRI) Study on Transgender Liver Health

U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07746999) titled 'North Jersey Community Research Initiative (NJCRI) Study on Transgender Liver Health' on Feb... Read More


Clinical Trial: Effect of Modified Arm Positioning on Shoulder Pain After Thoracoscopic Lobectomy

U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07746323) titled 'Effect of Modified Arm Positioning on Shoulder Pain After Thoracoscopic Lobectomy' on July 2... Read More


Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, Aug. 6 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety... Read More


Clinical Trial: Role of Anticoagulation in the Management of Tumor Thrombus

U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07748234) titled 'Role of Anticoagulation in the Management of Tumor Thrombus' on June 02. Brief Summary: The... Read More


Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7-H4-Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, Aug. 6 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Mo... Read More


Clinical Trial: Assessment of Retinal Microvascular Changes by OCT Angiography in Diabetic Retinopathy

U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07747428) titled 'Assessment of Retinal Microvascular Changes by OCT Angiography in Diabetic Retinopathy' on J... Read More


Singapore Clinical Trial: DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in combination with atezolizumab, carboplatin, and etoposide vs. atezolizumab, carboplatin, and etoposide as first-line treatment in patients with extensive-stage small cell lung cancer

Singapore, Aug. 6 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in... Read More


Singapore Clinical Trial: An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of BAY 3771249 as monotherapy or combination with other cancer treatments in participants with solid tumors harboring a KRAS G12D mutation

Singapore, Aug. 6 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and e... Read More


Clinical Trial: Adaptive Optics Scanning Light Ophthalmoscopy (AOSLO) and Microperimetry (MP) Sub-study

U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07747662) titled 'Adaptive Optics Scanning Light Ophthalmoscopy (AOSLO) and Microperimetry (MP) Sub-study' on ... Read More


Singapore Clinical Trial: A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of asciminib in pediatric participants newly diagnosed or previously treated with Philadelphia positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) with or without known T315I mutation.

Singapore, Aug. 6 -- The Health Sciences Authority received information related to the study titled 'A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of ascimi... Read More